TCMD - יחס חוב להיוון בספרים tactilemedical.com

Risks for Tactile Systems Technology (TCMD) are linked to the revision of Medicare payments and sales staff costs, with the metric standing at 0.06. The price action chart reflects the dynamics of the lymphedema systems manufacturer's shares. Stability is ensured by partnerships with numerous insurance companies and clinics. Despite its narrow specialization, Tactile Systems Technology (TCMD) leads the US market, generating revenue from the regular sale of ancillary materials.

This indicator reflects the proportion of borrowed funds relative to the value of net assets, allowing a conservative investor to assess the real financial stability and the degree of the business's dependence on creditors. By analyzing the dynamics of debt obligations to balance sheet capital, one can determine the margin of safety for Tactile Systems Technology (TCMD) given that revenue depends on insurance company decisions regarding the reimbursement of lymphedema therapy costs.